Clinical Trial Update: Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing plasmapheresis to plasma infusion from young APOE3 homozygotes in APOE4 homozygote individuals with mild cognitive impairment, to asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Plasma infusion from young APOE3 homozygotes
• plasmapheresis

Snippet

Sponsor: Mayo Clinic | Conditions: Mild Cognitive Impairment | Phase 1 | Status: COMPLETED